ImageneBio (IMA) Share-based Compensation (2020 - 2025)

ImageneBio has disclosed Share-based Compensation across 6 years of filings, most recently posting $7.5 million for Q3 2025.

• In Q3 2025, Share-based Compensation fell 8.12% year-over-year to $7.5 million; the TTM figure through Sep 2025 stood at $7.5 million (down 8.12% YoY), while the FY2024 annual figure was $5.3 million, down 52.72% from the prior year.
• Share-based Compensation came in at $7.5 million for Q3 2025 at ImageneBio, up from $6.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $8.7 million in Q1 2024 to a low of $1.6 million in Q4 2021.
• Average Share-based Compensation over 5 years is $6.0 million, with a median of $6.5 million recorded in 2025.
• Year-over-year, Share-based Compensation surged 1341.75% in 2021 and dropped 24.8% in 2025.
• Over 5 years, Share-based Compensation stood at $1.6 million in 2021, then climbed by 17.58% to $1.9 million in 2022, then retreated by 5.59% to $1.8 million in 2023, then surged by 201.71% to $5.3 million in 2024, then jumped by 41.64% to $7.5 million in 2025.
• Per Business Quant data, the three most recent Share-based Compensation figures were $7.5 million in Q3 2025, $6.3 million in Q2 2025, and $6.5 million in Q1 2025.